The effect of D2E7, a new human anti-TNFα monoclonal antibody, on the oxidative burst of PMN in patients with RA.

被引：0
|
作者：
den Broeder, AA
Wanten, GJA
van Riel, PLCM
Kroot, EJ
Naber, THJ
Barrera, P
机构：
[1] Univ Nijmegen Hosp, Dept Rheumatol, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen Hosp, Dept Gastroenterol, NL-6500 HB Nijmegen, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 1998年 / 41卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
150
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [41] Tumor necrosis factor (TNF) microsatellite haplotypes and perinuclear anti-neutrophil cytoplasmic antibody (pANCA) identify Crohn's disease (CD) patients with poor clinical responses to anti-TNF monoclonal antibody (cA2)
    Plevy, SE
    Taylor, K
    DeWoody, KL
    Schaible, TF
    Shealy, D
    Targan, SR
    GASTROENTEROLOGY, 1997, 112 (04) : A1062 - A1062
  • [42] Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study
    Taylor, Peter C.
    Schett, Georg
    Huizinga, Tom W. J.
    Wang, Qingmin
    Ibrahim, Fowzia
    Zhou, Bei
    Liva, Sophia G.
    Shaik, Jafar Sadik B.
    Xiong, Yuan
    Leu, Jocelyn H.
    Panchakshari, Rohit A.
    Loza, Matthew J.
    Ma, Keying
    Dhatt, Harman
    Rojo Cella, Ricardo
    Karyekar, Chetan S.
    Cuff, Carolyn A.
    Gao, Sheng
    Fei, Kaiyin
    RMD OPEN, 2024, 10 (02):
  • [43] Efficacy and safety of anti-fractalkine monoclonal antibody, E6011, in patients with Crohn's disease who had lost response to anti-TNFα agents: A multicentre, open-label, Phase 1/2 study
    Matsuoka, K.
    Naganuma, M.
    Tanida, S.
    Kitamura, K.
    Matsui, T.
    Arai, M.
    Fujiya, M.
    Horiki, N.
    Nebiki, H.
    Kinjo, F.
    Miyazaki, T.
    Matsumoto, T.
    Esaki, M.
    Mitsuyama, K.
    Saruta, M.
    Ido, A.
    Hojo, S.
    Takenaka, O.
    Oketani, K.
    Imai, T.
    Tsubouchi, H.
    Hibi, T.
    Kanai, T.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S70 - S70
  • [44] Long-term follow-up of the changes in circulating cytokines, soluble cytokine receptors, and white blood cell subset counts in patients with rheumatoid arthritis (RA) after monoclonal anti-TNFα antibody therapy
    Ohshima, S
    Saeki, Y
    Mima, T
    Sasai, M
    Nishioka, K
    Ishida, H
    Shimizu, M
    Suemura, M
    McCloskey, R
    Kishimoto, T
    JOURNAL OF CLINICAL IMMUNOLOGY, 1999, 19 (05) : 305 - 313
  • [45] Long-Term Follow-Up of the Changes in Circulating Cytokines, Soluble Cytokine Receptors, and White Blood Cell Subset Counts in Patients with Rheumatoid Arthritis (RA) After Monoclonal Anti-TNFα Antibody Therapy
    Shiro Ohshima
    Yukihiko Saeki
    Toru Mima
    Mitsuko Sasai
    Katsuhiro Nishioka
    Hiroshi Ishida
    Masatoshi Shimizu
    Masaki Suemura
    Richard McCloskey
    Tadamitsu Kishimoto
    Journal of Clinical Immunology, 1999, 19 : 305 - 313
  • [46] Sustained effect of leukocytapheresis/granulocytapheresis versus anti-human TNF-α monoclonal antibody on ulcerative colitis: A 2-year retrospective study
    Sakai, Masahiro
    Hayashi, Koichi
    Ito, Tomoyuki
    Otani, Haruka
    Mori, Yuya
    Ito, Shinsuke
    Endo, Keita
    Matsuda, Hiroto
    Yoshino, Kaede
    Kitamura, Koichi
    Kubota, Eiji
    Motomura, Yasuaki
    Suzuki, Yasuhiro
    Fujitani, Shigeki
    Suzuki, Toshihiko
    MEDICINE, 2023, 102 (16) : E33368
  • [47] Adaptation to blockade of human immunodeficiency virus type 1 entry imposed by the anti-CCR5 monoclonal antibody 2D7
    Aarons, EJ
    Beddows, S
    Willingham, T
    Wu, LJ
    Koup, RA
    VIROLOGY, 2001, 287 (02) : 382 - 390
  • [48] 52-WEEK RESULTS OF CLINICAL, RADIOGRAPHIC AND PHARMACOKINETIC ASSESSMENTS: GOLIMUMAB, A HUMAN ANTI-TNF MONOCLONAL ANTIBODY, ADMINISTERED SUBCUTANEOUSLY EVERY FOUR WEEKS IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY
    Tanaka, Y.
    Harigai, M.
    Takeuchi, T.
    Yamanaka, H.
    Ishiguro, N.
    Yamamoto, K.
    Kanazawa, M.
    Murakami, Y.
    Yoshinari, T.
    Baker, D.
    Miyasaka, N.
    Koike, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 372 - 372
  • [49] 52-Week Results of Clinical, Radiographic and Pharmacokinetic Assessments: Golimumab, a Human Anti-TNF Monoclonal Antibody, Administered Subcutaneously Every Four Weeks in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy
    Tanaka, Yoshiya
    Harigai, Masayoshi
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Yamamoto, Kazuhiko
    Kanazawa, Minoru
    Murakami, Yoshinori
    Yoshinari, Toru
    Baker, Daniel G.
    Miyasaka, Nobuyuki
    Koike, Takao
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S175 - S175
  • [50] Golimumab, A Human Anti-TNF Monoclonal Antibody, Administered Subcutaneously Every Four Weeks As Monotherapy in Patients with Active Rheumatoid Arthritis Despite DMARD Therapy: 52-Week Results of Clinical, Radiographic and Pharmacokinetic Assessments
    Takeuchi, Tsutomu
    Harigai, Masayoshi
    Tanaka, Yoshiya
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Yamamoto, Kazuhiko
    Kanazawa, Minoru
    Murakami, Yoshinori
    Yoshinari, Toru
    Baker, Daniel G.
    Miyasaka, Nobuyuki
    Koike, Takao
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S176 - S176
12345